196 related articles for article (PubMed ID: 1357623)
1. The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.
Furukawa CT; Kemp JP; Simons FE; Tinkelman DG
Pediatrics; 1992 Oct; 90(4):639-40. PubMed ID: 1357623
[No Abstract] [Full Text] [Related]
2. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
[No Abstract] [Full Text] [Related]
3. Asthma deaths in New Zealand: whodunnit?
Blauw GJ; Westendorp RG
Lancet; 1995 Jan; 345(8941):2-3. PubMed ID: 7799701
[No Abstract] [Full Text] [Related]
4. Evidence based answers--is salmeterol safe in asthma?
Spurling G; Doust J
Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
[No Abstract] [Full Text] [Related]
5. Long acting beta 2 agonists and the risk of life threatening asthma.
Ernst P
Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
[No Abstract] [Full Text] [Related]
6. Inhaled beta-adrenergic receptor agonists in asthma: more harm than good?
Barrett TE; Strom BL
Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):574-7. PubMed ID: 7842223
[No Abstract] [Full Text] [Related]
7. [Increased asthma fatality in chronic administration of beta agonists?].
Geisler LS
Dtsch Med Wochenschr; 1993 Feb; 118(6):206-7. PubMed ID: 8094666
[No Abstract] [Full Text] [Related]
8. Epidemiologic studies of beta agonists and asthma deaths.
Pearce N; Hensley MJ
Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
[No Abstract] [Full Text] [Related]
9. The use of beta agonists and the risk of death and near death from asthma.
Pearce N
J Clin Epidemiol; 2009 Jun; 62(6):582-7. PubMed ID: 19422997
[No Abstract] [Full Text] [Related]
10. Beta-agonists and death from asthma.
Pearce N; Crane J; Burgess C; Beasley R; Jackson R
N Engl J Med; 1992 Jul; 327(5):355-7. PubMed ID: 1352379
[No Abstract] [Full Text] [Related]
11. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
Lanes SF; Birmann B; Raiford D; Walker AM
J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
[TBL] [Abstract][Full Text] [Related]
12. [Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage].
Larsson K
Lakartidningen; 1991 Oct; 88(44):3643-5. PubMed ID: 1682539
[No Abstract] [Full Text] [Related]
13. [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma].
Yamamoto H; Nagata M; Tabe K; Suzuki S; Maruo H; Sakamoto Y; Yamamoto K; Dohi Y
Arerugi; 1990 Jan; 39(1):21-7. PubMed ID: 1972011
[TBL] [Abstract][Full Text] [Related]
14. [Bronchial asthma. Its treatment in the emergency ward].
Diez Jarilla JL; Cruz Hernández JJ; del Pino Montes J; Sánchez Gascónf ; Laso Guzmán FJ
Med Clin (Barc); 1981 Oct; 77(6):262-3. PubMed ID: 6119406
[No Abstract] [Full Text] [Related]
15. [Bronchospasmolytic effect of adrenergic beta receptor agonists in bronchial asthma].
Makel'skiĭ VV
Ter Arkh; 1976; 40(2):57-60. PubMed ID: 9700
[No Abstract] [Full Text] [Related]
16. Beta 2 agonists in asthma: relief, prevention, morbidity.
Lancet; 1990 Dec; 336(8728):1411-2. PubMed ID: 1978875
[No Abstract] [Full Text] [Related]
17. Asthma. Bronchodilators: new developments.
Tattersfield AE
Br Med Bull; 1992 Jan; 48(1):190-204. PubMed ID: 1352168
[TBL] [Abstract][Full Text] [Related]
18. [Adrenergic beta 2-agonists are to be considered more as friends than enemies].
Löfdahl CG; Svedmyr N
Lakartidningen; 1992 Aug; 89(32-33):2572-3. PubMed ID: 1354780
[No Abstract] [Full Text] [Related]
19. The saga of the New Zealand asthma mortality epidemic.
N Z Med J; 1995 Mar; 108(995):91. PubMed ID: 7661939
[No Abstract] [Full Text] [Related]
20. Routine use of beta-adrenergic agonists in asthma.
Wanner A; Sears MR
Am J Respir Crit Care Med; 1995 Aug; 152(2):823. PubMed ID: 7633750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
